Approach

AuraGxP

Proactive Compliance. Predictable Economics

Approach

Unifying Quality, Procurement,Vendor Oversight & Spend management in One AI-Empowered Solution

AuraGxP aims to eliminate the fragmentation that delays clinical trials and erodes governance by uniting Quality, Procurement, Vendor Oversight, and Spend under a single audit-ready framework.

35%

Faster vendor
selection & onboarding

Streamline vendor qualification, approvals, and onboarding with centralized workflows that reduce delays and improve cross-functional visibility.

40%

Improved quality
& audit readiness

Maintain inspection-ready documentation, training, and quality processes with real-time oversight across regulated operations.

50%+

Of trial delays caused
by quality gaps

Disconnected systems and manual processes create costly delays, Quality risks, and operational inefficiencies across clinical and quality functions.

The Fragmentation Tax

Clinical Complexity Demands Unified Oversight.

Life Sciences organizations running clinical trials face a silent, costly adversary: fragmentation. Vendor data lives in spreadsheets. Contracts are buried in static documents. Quality, procurement, and finance operate in separate silos — each generating blind spots.

These disconnected systems don't just slow teams down. They create regulatory exposure, budget overruns, and missed obligations that compound across Phase I–III timelines.

The C⁴ Advantage

Four Pillars. One Integrated Framework.

Every component of AuraGxP is designed around four interlocking principles that span the entire clinical trial lifecycle — from first vendor engagement to final audit.

COMPLIANCE

GxP-compliant workflows aligned with FDA and EMA standards. Every step is documented, defensible, and inspection-ready.

CONTROL

Full traceability across SOPS, training records, CAPA workflows, and vendor performance. Nothing falls through the cracks.

COST

Architected for multi- vendor clinical environments. Real- time budget visibility prevents overruns and eliminates spend leakage.

CONTINUITY

Supports scaling biotech teams across Phase I-III trials. The framework grows with your program — not against it.

The Four Fragmentation Risks

How disconnected systems create operational risk and inefficiency.

01

Spreadsheet-driven vendor selection leads to biased decisions, inconsistent scoring, and poor downstream outcomes.

02

Lengthy, unstructured RFP cycles delay
execution and inflate opportunity cost across trial phases.

03

Contracts buried in static documents create risk exposure and allow critical obligations to slip unnoticed.

04

Disconnected quality, Quality, procurement, and finance functions systematically weaken governance at scale.

Ready to unify Quality, Procurement, Vendor Oversight and Spend

Leverage our expertise in quality process management; vendor assessment, management, and oversight; and spend reconciliation.

info@auragxp.com

www.auragxp.com

1 Broadway, Cambridge MA 02142

Explore Solutions Talk to our Experts